Purpose: Mimetics based on Smac, the native inhibitor of XIAP, are promising drugcandidates for the treatment of cancer. Bivalent Smac mimetics inhibit XIAP with even higher potency than monovalent mimetics, but how to optimize the linker that tethers the two monovalent binding motifs remains controversial. Methods: To construct an ensemble of bivalent complex structures for evaluating various linkers, we propose herein a workflow, named TwistDock, consisting of steps of monovalent docking and linker twisting, in which the degrees of freedom are sampled focusing on the rotation of single bonds of the linker. Results: The obtained conformations of bivalent complex distribute randomly in the conformational space with respect to two reaction coordinates introduced by the linker, which are the distance of the two binding motifs and the dihedral angle of the two planes through the linker and each of the binding motifs. Molecular dynamics starting from 10 conformations with the lowest enthalpy of every complex shows that the conformational tendency of the complex participated by compound 9, one of the compounds with the largest binding affinity, is distinct from others. By umbrella sampling of the complex, we find its global minimum of the free energy landscape. The structure shows that the linker favors a compact conformation, and the two BIR domains of XIAP encompass the ligand on the opposite sides. Conclusion: TwistDock can be used in fine-tuning of bivalent ligands targeting XIAP and similar receptors dimerized or oligomerized.
Introduction
Apoptosis, or programmed cell death, is critical for multicellular organisms to maintain homeostasis. The IAP (Inhibitor of Apoptosis Protein) family, especially XIAP (X chromosome-linked IAP), inhibits apoptosis of cancer cells. 1 However, Most antagonists of XIAP are designed mimicking the AVPI sequence, 18, 19 in order to balance out the overexpression of XIAP in tumor cell and overwhelm the apoptosis resistance. 20, 21 Monovalent Smac mimetics have a single binding motif, which generally binds to BIR3 with a high affinity. 19 Bivalent Smac mimetics have two binding motifs binding to BIR2 and BIR3 simultaneously. 6 Bivalent Smac mimetics induced apoptosis with even higher activity than that of native Smac and monovalent Smac mimetics. 8, [10] [11] [12] [13] [14] [15] 17 The reason that bivalent Smac mimetics acquire even higher pro-apoptotic activity resides not only in the general strategy to increase the binding affinity, but also in the regulation mechanism of XIAP to apoptosis. Apoptosis is initiated through two pathways: the intrinsic pathway and the extrinsic pathway. 17, 22 In the intrinsic pathway, mitochondria releases cytochrome c and initiates the pathway, often due to chemotherapeutics or radiation stimulation, and then an initiator caspase-9 is activated. 23 The extrinsic pathway is triggered through the binding of death receptor and death ligand, like CD95 ligand, TNF and TRAIL, and the signaling is passed by caspase-8. 18 , 24 The two pathways finally converge on effectors caspase-3/7 at downstream. Caspase-3 and -7 determine the apoptosis of cell through cleavage of critical cellular substrates such as poly(ADPribose) polymerase and lamins. 17, 25 The BIR2 domain of XIAP with the linker to its N-terminal inhibits caspase-3 and caspase-7, while the BIR3 domain targets caspase-9.
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Over-expression of XIAP in some tumor cell lines blocks the apoptosis pathways and diminishes the efficacy of chemotherapy and radiotherapy. 2, 4, 21 Monovalent Smac mimetics compete with only caspase-9 for XIAP and ignore the interaction of BIR2 with caspase-3/-7; thus, they are generally less potent than bivalent Smac mimetics. 6, 17, 19, 27 Attributed to the simultaneous inhibition of caspase-3, -7 and -9, 28, 29 bivalent Smac mimetics become attractive. On one hand, some of these mimetics have been proved to possess high binding affinity to XIAP and dramatically increased anticancer activity. Among these, a series of bivalent Smac mimetics with different linkers has been studied by Peng et al. experimentally to evaluate the impacts of linkers on the binding affinity and the anticancer activity. 28, 29 These studies provide biochemical and cellular biological evidence that they are promising lead compounds. On the other hand, a study performed with geneknock-out cells and mice suggested that the increased binding affinity to XIAP may be not always beneficial, ie, it introduces toxicity to animals. 30 To fine-tune the activity of antagonists to XIAP, structural insights into the relationship of linkers and binding affinity can rationalize the design of the linker, help us exploit the properties of the linker and aid virtual screening. A bivalent ligand has two binding motifs to its targeted receptor, which is usually a protein with multiple domains or dimerized protein. Introducing bivalency in ligand design provides new tunable parameters for optimization of the drug itself and its interaction with targets. For example, bivalency is a strategy to increase the binding affinity, especially through reducing the binding enthalpy. 31 Designing a bivalent ligand faces, in addition to the design of its monovalent binding motifs, two new issues concerning the linker tethering the two binding motifs: the selection of a suitable tethering site and the design of the linker with optimal length and other properties. 28 However, there is yet no agreement on the design principle of the linker. Although the length of the linker is intuitively of high importance, independent studies on bivalent Smac mimetics showed that the length of the linker may have different effect, from high to only modest, on binding affinity. 28, 29 Besides the length of the linker, twisting or torsion of the linker, which may determine the orientation of the two binding motifs, should be also an important factor affecting the binding affinity. Twisting of the linker imposes limitation on the arrangement of binding domains of receptors. Different arrangements of the binding domains introduce various steric hindrance and electrostatic interaction between them, affecting the binding affinity. Unfortunately, the importance of this factor has yet been discussed by few studies, especially on the computational modeling. Actually, as far as we know, there are no published or commercially available docking software that constructs an ensemble of bivalent complex and provides structural insights into the roles of the linker. In this study, we propose a high-efficiency workflow, named TwistDock, to implement the bivalent docking job, ie, to construct reasonable structures of bivalent complex. Exploiting the structural feature that the two BIR domains of XIAP are loosely concatenated by a peptide chain of 34 amino acids long and each of the two is bound independently by one of the binding motifs of the bivalent ligand, 11, 17, 28, 32 the workflow neglects the concatenating peptide and allows moving of the BIR2 and BIR3 domains. By twisting the linker and constraining the two binding interfaces, possible arrangements of the BIR2 and BIR3 domains are enumerated. The enumerated conformations are then clustered and the redundant conformations are excluded. In this manner, the sampled degrees of freedom are mainly related to the twisting of the linker of the bivalent ligand, avoiding the atomic-level details that are expensive to sample. 33 The excluding of redundant conformations guarantees that the remaining conformations are unique and distant from each other in the conformational space. We constructed a series of complex formed by the BIR2 and BIR3 domains of XIAP and bivalent Smac mimetics of different linkers but the same binding motif. The structures are further equilibrated by molecular dynamics (MD) simulation, to introduce possible interactions between the BIR2 and BIR3 domains. Sampled conformations of one of the complexes, whose ligand is compound 9, are also subjected to umbrella sampling and the weighted histogram analysis method (WHAM) for the free energy landscape. With the structures, we clarify the role of the linker and discuss how the length and the twisting modulate the binding affinity of bivalent Smac mimetics.
Materials and methods

Construction of the bivalent complexes
The BIR2 domain used in the paper corresponds to residues E163 to V230 of XIAP, while the BIR3 domain corresponds to residues Y265 to L330 of XIAP. The structures of BIR2 and BIR3 were extracted from PDB entries 4J46 27 and 1G73, 34 respectively. Eight bivalent Smac mimetics, whose binding affinities to XIAP were measured by Peng et al. 28 , are studied in this paper ( Figure 1A ). Such a mimetic consists of two binding motifs derived from AT-406, a potential drug being tested in clinical trials, 19 and a linker tethers the two through the amide group in the eight-membered ring of AT-406. Structures of 8 bivalent Smac mimetics were generated with Simplified Molecular Input Line Entry Specification (SMILES) 35 representations according to the structures reported by Peng et al. 28 , via the distance geometry approach provided by RDKit. 36, 37 Each generated bivalent Smac mimetic structure was energy minimized for 500 steps with MMFF94 forcefield. 38 Because in some of the bivalent Smac mimetic structures the two binding motifs were distorted, these parts of the structures were refined by a substitution with the AT-406 structure obtained from Selleck Chemicals. 39 Docking for the two monovalent complexes, AT-406/BIR2 and AT-406/BIR3, was performed separately using AutoDockVina. 40 The docking was limited to the groove surface of BIR2 or BIR3 for binding AVPI, with the exhaustiveness set to 100 and the number of result binding poses set to 20.
For the monovalent complex of AT-406/BIR3, the structure with the highest docking score had a similar binding mode to the complex in PDB entry 1G73 (RMSD 1.056 Å). This structure was subjected to a 25 ns MD simulation ( Figure S1 ), where the ligand (AT-406) was parameterized with GAFF forcefield and AM1-BCC method using Antechamber 41 and the receptor (BIR3) was parameterized with Amberff14SB forcefields. Solvation and ionization was done in LEaP. 42 In the receptor, the zinc divalent cation, which is far away from the binding site, coordinated with four residues, was parameterized through the CaDA (Cationic Dummy Atom) approach. 43 The receptor was capped with neutral termini, ie, acetyl N-terminus (ACE) and methylamine C-terminus (NME). The solvation box was 58×57×58 Å 3 . With NAMD, 44 we ran 50,000 steps minimization of hydrogen atoms and water; 50,000 steps minimization of the receptor sidechains (except the four residues coordinating the zinc ion); 30 ps heating the system to 300 K; 5 ns equilibration in NpT ensemble; 2 ns equilibration in NVT ensemble; and finally 25 ns free dynamics, ie, MD simulation in NVT ensemble at 300 K and without any constraints. The density of the simulation system was watched and we detect no stable vacuum bubble formed.
For the monovalent complex of AT-406/BIR2 ( Figure S2 ), the structure with the third highest docking score was selected for subsequent MD simulation, because it has a binding mode most similar to the complex formed by the AVPI sequence and the BIR2 domain in PDB entry 4J46 (RMSD 1.123 Å). Parameterization and setup of the MD simulation were the same as the complex of AT-406/BIR3. The solvation box was 63×54×56 Å 3 .
After the MD simulations, the two monovalent complexes were linked together with a chemical linker (shown in Figure 1A ) tethering the two AT-406 molecules, by aligning the AT-406 molecules in monovalent complexes with the two AT-406 groups in the bivalent mimetic.
Conformational sampling of bivalent complex
The core step of the TwistDock workflow implements the conformation sampling by twisting the linker tethering the two IAP binding motifs of a bivalent Smac mimetic. Through interfaces of the IAP-binding motifs to the BIR2 and BIR3 domains, the twisting of the linker ultimately determines the global conformation of the entire bivalent complex. A flowchart shows the steps for building the bivalent complex and the conformational sampling of bivalent complex in Figure 2 .
We applied the workflow to a series of bivalent Smac mimetics, 8 compounds having the same IAP-binding motifs but different linkers, shown in Figure 1A . Compounds 8 to 12 have a linear alkane chain of 2-10 carbon atoms; compounds 13 and 14 have a linker chained by two linear alkane groups of 4 carbon atoms and, respectively, a phenylene group and an oxygen atom; and compound 15 has a phenylene ring as the linker chain. Twisting of the linker was achieved by rotation of C-C and C-O single bonds of a bared linker chain capped with N,N-Dimethylformamide groups on two ends of the linker. With the distance geometry approach 36 provided by RDKit, 100,000 chain conformations for each linker chain were randomly generated. Each generated structure was energy minimized for 500 steps with MMFF94 forcefield. 38 These conformations were clustered using the quality threshold (QT) algorithm 45 implemented in VMD 46 (parameters detailed in Table S1 and S2 and Figure S3 ). All but the first conformation in a cluster were excluded, so that the remaining conformations were distant from each other in the conformational space. A chain conformation replaced the linker part within a bivalent complex structure, by aligning the termini of the chain to the amide group in the eight-membered ring of the AT-406 part. The alignment allowed translation and rotation of the AT-406/BIR2 and the AT-406/BIR3 parts, but the two monovalent parts themselves were moved entirely as rigid bodies. Bivalent complexes whose structures were invalid, ie, the AT-406/BIR2 part overlapped with the AT-406/BIR3 part, were discarded. At the end, an ensemble of conformations of every bivalent complex was obtained.
Minimization and equilibration of the bivalent complex structures
Each structure in an ensemble obtained by our TwistDock workflow was relaxed by a 1,000-step minimization. For compounds 8, 9 and 15, because their linker chains are less flexible, RDKit produced few unique conformations (Table S1 ) even before clustering. Since more independent structures are needed by the subsequent analysis, we ran more parallel trajectories of minimization to compensate the small number of valid bivalent complex structures (Table S1 ). Subsequently, MD simulation consisted of a 40 ps run with C α -atom restraints and two 10 ps runs of equilibration was carried out with PMEMD provided in the AMBER package. 42 The minimization and MD were all performed in implicit solvent condition using the generalized Born model with a counterion concentration of 0.1 mol/L. Extracted from the last 10 ps equilibration, 10 frames of every 1 ps were evaluated for the enthalpy of complex (H complex ) using the MM-GBSA method with MMPBSA.py provided in the AMBER package. 47 The hydrophobic contribution to the enthalpy was calculated by the LCPO method. 48 The salt concentration was 0.1 M. The receptor was set to the BIR2 and BIR3 domains as a whole, and the ligand was set to the bivalent Smac mimetic. We only compared the complex enthalpy among structures of an ensemble of the same complex, instead of calculating the enthalpy of the ligand and receptor parts and reporting the difference. We obtained 10 bivalent complexes with the lowest complex enthalpy for each of the eight bivalent Smac mimetics ( Figure S4 ). In total, 80 complexes were subject to a 2 ns MD. Parameterization of the bivalent complex for MD simulation was similar to the monovalent complex described above, using GAFF for ligand, Amber forcefields for proteins, the CaDA approach for zinc ions and the coordinating residues, and the ACE and NME termini.
Umbrella sampling
To demonstrate the effects of length and twisting of the linker, we project the conformation space of a bivalent complex on a plane of two reaction coordinates: distance B3-B2 (denoted by ξ) and dihedral B3-L3-L2-B2 (denoted by α) ( Figure 1B ). The points B3 and B2 are the centers of mass of the (8,5)-bicyclic cores of the AT-406 parts bound to, respectively, BIR2 and BIR3. The distance B3-B2 (ξ) reflects the length of the linker and is also related to the distance between the BIR2 and BIR3 domains. The points L3 and L2 are defined as the terminal atoms of the linker chain connected to the AT-406 parts bound to, respectively, BIR3 and BIR2. The dihedral B3-L3-L2-B2 (α) reflects the twisting of the linker and is also related to the rotation of the BIR2 and BIR3 domains. The arrangement of the BIR2 and BIR3 domains in a bivalent complex is uniquely described by ξ and α. We performed the umbrella sampling with PMEMD in the AMBER package 42 for the bivalent complex formed by compound 9 and the BIR2 and BIR3 domains. The ensemble of this complex obtained by our TwistDock workflow consists of 31 structures. Each structure was relaxed by a 1,000-step minimization and equilibrated with a 40 ps run with C α -atom restraints and a 10 ps equilibration, in which each last frame was used as the starting point of 8 independent biased MD. Totally, 248 biased MD simulations of 8 ns long were carried out. Restraints were set up along ξ and α. Along ξ, the restrain window was centered on the value of ξ in the structure of the starting point. Along α, the restrain window was centered on one of eight values from {0, 15, 30, …, 345°} that are within ±60°near the value of the dihedral α in the structure of the starting point. The two reaction coordinates were restraint by harmonic potentials of 0.01 kcal/(mol·Å 2 ) and 1 kcal/ (mol·rad 2 ), respectively. Structures of every 0.1 ps in the last 2 ns of these trajectories were collected and combined to form the free energy surface by WHAM. 
Results
TwistDock workflow building a conformation ensemble of bivalent complex
The system of a bivalent complex formed by XIAP and a bivalent Smac mimetic has a huge number of degrees of freedom. However, since the BIR2 and BIR3 domains of XIAP are loosely linked by a peptide chain of 34 amino acids, the degrees of freedom that significantly affect the interaction of the receptor and ligand reside in the arrangement of the BIR2 and BIR3 domains. The bivalent ligand has two IAP-binding motifs each of which is bound to one of the BIR2 and BIR3 domains. If we neglect the peptide chain, the arrangement of the BIR2 and BIR3 domains is defined by only the conformation of the linker of the bivalent ligand. Our TwistDock workflow can enumerate the conformation of the linker and based on it construct a conformation ensemble of the bivalent complex. For each of the 8 linkers ( Figure 1A) , we obtained 100,000 conformers. The number should be sufficient, because even for compound 12 which has the longest linker, we find most of the conformers are redundant and only 11,507 are unique (Table S1 ). For compounds 8 and 15, which have short linkers, the numbers of unique conformers are even much smaller (Table S1 ). To save computational resource in subsequent steps, the conformations were clustered and only one representative conformation of a cluster was kept. We tried three sets of cutoff for clustering and found that the distributions of clusters were insensitive to different cutoff, suggesting the cutoff we used was small enough to distinguish significantly different conformation (Table S2 and Figure S3 ). The clustering step makes the samples uniformly distribute over the conformational space, more regularly than random samples, following the idea of quasi Monte Carlo method. 50 The coverage of the sampling can be visualized by projecting the conformational space of bivalent complexes on the two reaction coordinates ξ and α (Figure 3 ). For all of the complexes, the conformations distribute randomly with respect to the two reaction coordinates, while the range along ξ is limited by the length and possibly flexibility of the linkers, in contrast to the range along α, which has no limitation. The two reaction coordinates are independent, except that small value of ξ is only permitted when α is near 0°. Complexes involving ligands with short linkers have fewer unique conformation samples, indicating their small conformational spaces.
Many of the conformation samples are invalid structure, since they contain overlapping heavy atoms in the bivalent complex. The distribution of valid structure is even more limited, but still covers the available space. Valid structures with small ξ tend to have α away from 0°, meaning that they keep the BIR2 and BIR3 domains away from each other.
Conformational tendency of bivalent complex with low free energy
With the conformation ensemble, we aim at finding the structure that has the lowest free energy and is most close to the native stable conformation. First, we performed parallel runs consisting of minimization and short MD for all structures sampled by our TwistDock workflow to relax the structures and to explore the conformational space. Every structure was evaluated for the enthalpy averaged in its short MD. We compared the complex enthalpy among the parallel runs within an ensemble ( Figure S4) .
The end frames of trajectories of 10 structures with the lowest enthalpy were further analyzed with long MD. During the MD, the dihedral B3-L3-L2-B2 (α) fluctuated around a mean value in every trajectory of bivalent complexes, and the narrow range indicates that the system stays close to the structure of the local minimum of energy. In trajectories of bivalent complexes formed by XIAP and compounds 8 or 15, the mean values of α are closed to ±180° (Figure 4 , A and H). These two bivalent complexes prefer the conformation in which the BIR2 and BIR3 domains stay on opposite sides of the bivalent Smac mimetic. Because the linkers of the two compounds are short but the BIR2 and BIR3 domains are large and both negatively charged, such a conformation allows the two domains to keep a long distance so as to minimize the free energy of the bivalent complex. In trajectories of bivalent complexes involving compounds 10, 11, 12, 13 and 14, the mean values of α are also closed to ±180°, but the circular distributions show that they have no conformation preference (Figure 4 , C, D, E, F and G). The linkers of these compounds are long enough so that the BIR2 and BIR3 domains can keep far away from each other with any value of α. In trajectories of bivalent complex formed by the BIR2 and BIR3 domains and compound 9, the circular distribution of α is different to that of other bivalent complexes ( Figure 4B ). The value is close to 0°, instead of close to ±180°, and its overall distribution is less uniform than that of compounds 10, 11, 12, 13 and 14. The preference of the reaction coordinate α may be a structural feature that results in the high potency of compound 9 ( Figure 1A ). Distance B3−B2 (Å) Figure 3 Conformational spaces of 8 bivalent complexes sampled by TwistDock, projected on reaction coordinates distance B3-B2 (ξ) and dihedral B3-L3-L2-B2 (α). Red crosses denote invalid conformations that have serious structural clashes, while green circles denote valid conformations. The bivalent complex is formed by the BIR2 and BIR3 domains and one of the bivalent Smac mimetics (A to H correspond to compounds 8 to 15). (Compound 9 has the compact conformational space, which is viable to explore).
The free energy landscape of the bivalent complex formed by compound 9 and the BIR2 and BIR3 domains
For a bivalent complex, the degrees of freedom that can be controlled by design of the linker in bivalent ligands are the distance B3-B2 (ξ) and the dihedral B3-L3-L2-B2 (α).
We performed umbrella sampling for the complex formed by compound 9 and the BIR2 and BIR3 domains to find its global minimum of the free energy landscape projected on reaction coordinates ξ and α. By WHAM, we obtained the free energy landscape ( Figure 5 ). The global minimum of the free energy is near ξ=9.25 Å, α=−25°. Besides the global minimum, there are two major local minima, which are near ξ=9.25 Å, α=−75°and ξ=12.25 Å, α=165°, and several minor local minima near the global minimum and the two major local minima. The entire low energy area is wedge-shaped, whose tapered side points to ξ=6 Å, α=0°.
Structure of the bivalent complex formed by compound 9 and the BIR2 and BIR3 domains
By umbrella sampling for the complex participated by compound 9, we detect the free energy minimum near the reaction coordinates ξ=9.25 Å, α=−25°. To visualize a complex near the free energy minimum in the conformational space, we examine the 10 trajectories of 2 ns equilibration. Three structures at time 1.625, 1.710, 1.780 ns from one of the 8 independent trajectories have reaction coordinates ξ≈9 Å, and respectively, α≈−24, −22.5, −26.0°( Figure 6 ), which should be very close to the native structure of the complex. In these structures, the linker of compound 9 adapts a compact conformation, and the two binding motifs encompass the ligand on the opposite sides. Such a conformation resembles the complexes formed by two BIR domains and other bivalent ligands ( Figure S5) . 15, 51 The distance between BIR2
and BIR3 domains becomes much shorter than that of the two domains in unbound XIAP. 12, 15, 20, 52 During the MD simulation, binding sites of the ligand kept a similar pattern of the starting structure of the MD simulation, in which the binding motifs of compound 9 were surrounded by residues Lys206, Leu207, Lys208, Asn209, Glu211, His223 and Phe224 of BIR2 and residues Gly306, Leu307, Thr308, Asp309, Lys311, Trp323 and Tyr324 of BIR3. Residues near the binding sites of the ligand are still able to interact with the residues belonging to the other BIR domain. Residue Lys208 of BIR2 forms salt bridge to Asp309 of BIR3 during the equilibration. Although the electrostatic interaction of this residue pair may contribute to the stability of the bivalent complex, each of the two BIR domains independently interact with one of the IAP-binding motifs of the ligand.
Discussion
A bivalent Smac mimetic consists of two binding motifs bound to BIR2 or BIR3 domain, and a linker tethering the two binding motifs. For designing a bivalent ligand, a short and rigid linker may result in spatial mismatch between the two binding motifs and the two domains, diminishing the gain of binding enthalpy of the second binding site, whereas a long and flexible linker raises the entropic cost for the binding and possibly shields the binding motifs. 31, [53] [54] [55] Taking advantage of the flexibility of the linker peptide between BIR2 and BIR3 domains, 32, 52 the arrangement of the BIR2 and BIR3 domains is almost free and may simultaneously fit to a bivalent ligand. Some bivalent Smac mimetics with short and rigid linkers and various binding motifs show binding activity to XIAP. 13, 15, 28, 51, 56 Comparing with the compounds with a long linker, homologs with a short linker do not always benefit from the reduced entropic effect for binding, as shown in experiments. 28 As have been shown, the BIR2 and BIR3 domains have an optimized arrangement maximizing the binding affinity for a bivalent Smac mimetic. This study proposed the TwistDock workflow to find out such an arrangement and to assist the design of a bivalent Smac mimetic. Our analysis demonstrates that a bivalent complex in general favors a bivalent ligand that the linker allows the two BIR domains stay far away, for example, a short linker that maintains the dihedral α about ±180°. Astonishingly, a further optimized bivalent ligand is the one that allows the BIR2 and BIR3 domains forming favorable interactions with each other, resulting in compact structure (Figures 6 and S5 ). According to this structure feature, we have designed and synthesized 5 novel inhibitors.
A WST-based cell growth assay suggests two of them are higher potent than compound 9 (unpublished data: IC50 of HL-60 cell is 0.058 and 0.028 μmol/L, compared to 0.088 μmol/L of compound 9; IC50 of SK-OV-3 cell is 0.096 and 0.034 μmol/L, compared to 0.084 μmol/L of compound 9). For drug design, recent studies performed with gene-knockout cells and mice suggest that the binding affinity to XIAP is not the only key feature. Efficiency of Smac mimetics at antagonizing XIAP, compared to cIAP1/2, is critical for determining if the drug is tolerated in animals. 30, 57 Antagonists with decreased ability to inhibit XIAP may improve the tolerability of animals, thus may be more promising drug candidates. 30 For testing a tunable linker in such a bivalent Smac mimetic as anti-cancer drugs, the TwistDock workflow may help virtual screening and optimization. There are other antagonists discovered by alternative approaches that are not based on Smac, such as fragment-based screening and macrocycle library screening. 9, 16 Though the benefit of this type of antagonists has not been fully documented, 
Conclusion
We developed the TwistDock workflow to construct reasonable structures of bivalent complex formed by XIAP and a bivalent Smac mimetic. Conformations sampled by the method provide good starting points for subsequent modeling study. The results show that in the bivalent complex formed by compound 9, the BIR2 and BIR3 domains stay on the opposite sides of the ligand while the two domains form beneficial interaction, which is the possible reason that compound 9 achieves high binding affinity. The TwistDock workflow can also be deployed for optimization of other bivalent ligands.
Supplementary materials Notes: * Valid structures are the bivalent complex structures without steric clashes, for example, overlapping of the monovalent complex of BIR2 with the monovalent complex of BIR3. ** Structures used subsequently are the structures used in the subsequent minimization and MD simulation. For compounds 10, 11, 12, 13 and 14, the structures used subsequently are the same as the valid structures; for compounds 8, 9 and 15, since the number of the valid structures is relatively small, the valid structures are subjected to subsequent minimization and MD simulation with several independent runs in order to have more structures for subsequent steps. Notes: * The standard cutoff for clustering is the condition used to produce structures for subsequent minimization and MD (also shown in Table S1 ), while the stringent or loose cutoff is for comparing with the standard one so as to evaluate the convergence of sampling.
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Figure S1 Figure S3 Distributions of clusters are insensitive to the clustering cutoff. For a bivalent complex, distributions are obtained in three sets of cutoff for clustering, where "standard" is the condition set used to produce the structures for the subsequent minimization and MD, "stringent" is the condition set resulting more structures and "loose" is the condition set resulting fewer structures. The names of the compounds that participate the formation of bivalent complexes are shown on the top line. In each distribution histogram, the xaxis denotes the value of (A) radius of gyration of the bivalent complex (R gyr ) or (B) the dihedral B2-L2-L3-B3, while the y-axis denotes the number of structures.
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